About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Prostate Specific Membrane Antigen Avid Thyroid Cancer in Patients with Prostate Cancer: A Report of Two Cases
Saranya Sasikala1, Anand Narayan Chinnachamy1, Arumugam Rajkumar2, Arulraj Pitchamuthu3
Departments of Radiation Oncology1, Medical Oncology2 and Surgical Oncology3, Valavadi Narayanasamy Cancer Center, G. Kuppuswamy Naidu Memorial Hospital, Coimbatore 641037, India.
Corresponding Author:
Dr. Saranya Sasikala
Email: drsaranyasasikala@gmail.com
Received: 10-MAY-2023 Accepted: 14-OCT-2023 Published Online: 15-NOV-2023
DOI: http://dx.doi.org/10.17659/01.2023.0029
Abstract
Background: Ga-68 labelled Prostate specific membrane antigen-Positron emission tomography (PSMA-PET) is widely used in staging of intermediate and high-risk prostate cancer or restaging after biochemical recurrence. Despite the term “prostate specific”, incidental uptake with Ga-68 PSMA-PET in benign and non-prostatic malignancy has been reported. Case Report: Here we present two cases of carcinoma prostate with PSMA-PET avid lesions in thyroid, requiring further evaluations due to its non-specificity and on evaluation found to be a synchronous double malignancy of prostate and carcinoma thyroid. Conclusion: PSMA-PET, though has high sensitivity and specificity in staging for prostate cancer, can be taken up by multiple other malignancies and non-malignant conditions. If clinical picture warrants, additional confirmatory investigations are required, might change the staging and the treatment. 
Keywords : Biopsy, Lung, Prostate, Prostate Specific Antigen, Staging, Thyroid.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports

abortion pill online

Secure abortion pill tablets. There he could simply order pill for abortion online generic.There we could simply order generic site.
Last updated on Apr 05, 2024